COSCIENS Biopharma Inc. (CSCI) — Financial Flexibility Index
COSCIENS Biopharma Inc. (CSCI) has a Financial Flexibility Index of -0.21x as of June 2025. Free cash flow of $-4.40 Million (operating CF $-4.45 Million minus capex $49.00K) represents 0% of total liabilities ($20.46 Million). Check cash flow reinvestment rate of COSCIENS Biopharma Inc. to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
COSCIENS Biopharma Inc. Financial Flexibility Index (1996–2024)
Historical Financial Flexibility Index trend for COSCIENS Biopharma Inc. across 29 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of COSCIENS Biopharma Inc..
Annual Financial Flexibility Index for COSCIENS Biopharma Inc. (1996–2024)
Year-by-year free cash flow to debt coverage for COSCIENS Biopharma Inc.. Explore COSCIENS Biopharma Inc. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.61x | $-13.41 Million | $-14.57 Million | $21.91 Million | ▲ +10.8% |
| 2023 | -0.69x | $-1.86 Million | $-2.58 Million | $2.71 Million | ▼ -152.6% |
| 2022 | 1.31x | $5.24 Million | $5.23 Million | $4.01 Million | ▲ +3.1% |
| 2021 | 1.27x | $3.31 Million | $2.75 Million | $2.61 Million | ▲ +22.7% |
| 2020 | 1.03x | $3.98 Million | $3.49 Million | $3.85 Million | ▲ +480.0% |
| 2019 | 0.18x | $675.30K | $675.29K | $3.79 Million | ▲ +143.3% |
| 2018 | -0.41x | $-636.58K | $-1.56 Million | $1.55 Million | ▼ -138.7% |
| 2017 | 1.06x | $4.45 Million | $1.25 Million | $4.19 Million | ▼ -57.0% |
| 2016 | 2.47x | $7.34 Million | $3.63 Million | $2.97 Million | ▲ +136.3% |
| 2015 | 1.05x | $5.90 Million | $2.87 Million | $5.64 Million | ▼ -13.4% |
| 2014 | 1.21x | $5.82 Million | $1.84 Million | $4.82 Million | ▲ +109.9% |
| 2013 | 0.58x | $2.62 Million | $460.21K | $4.56 Million | ▲ +1659.2% |
| 2012 | 0.03x | $127.37K | $-117.82K | $3.89 Million | ▼ -87.2% |
| 2011 | 0.26x | $914.92K | $791.62K | $3.58 Million | ▲ +57.4% |
| 2010 | 0.16x | $564.50K | $479.50K | $3.47 Million | ▲ +173.4% |
| 2009 | -0.22x | $-875.72K | $-925.47K | $3.96 Million | ▼ -44.2% |
| 2008 | -0.15x | $-658.07K | $-909.41K | $4.29 Million | ▼ -190.2% |
| 2007 | 0.17x | $521.15K | $-1.10 Million | $3.06 Million | ▲ +23.8% |
| 2006 | 0.14x | $207.32K | $140.59K | $1.51 Million | ▲ +187.5% |
| 2005 | -0.16x | $-264.57K | $-368.84K | $1.69 Million | ▼ -165.4% |
| 2004 | 0.24x | $320.33K | $-76.65K | $1.33 Million | ▲ +2.7% |
| 2003 | 0.23x | $157.47K | $54.42K | $673.27K | ▲ +188.0% |
| 2002 | 0.08x | $66.97K | $-57.75K | $824.69K | ▲ +117.1% |
| 2001 | -0.47x | $-450.28K | $-457.45K | $948.90K | ▼ -75.4% |
| 2000 | -0.27x | $-484.37K | $-506.44K | $1.79 Million | ▼ -196.4% |
| 1999 | -0.09x | $-138.09K | $-207.14K | $1.51 Million | ▲ +93.7% |
| 1998 | -1.44x | $-1.49 Million | $-1.62 Million | $1.04 Million | ▼ -140.9% |
| 1997 | 3.51x | $9.08 Million | $-3.14 Million | $2.59 Million | ▲ +766.1% |
| 1996 | 0.41x | $3.14 Million | $-1.39 Million | $7.73 Million | — |